Literature DB >> 25549593

Analysis of serum cytokine levels in larynx squamous cell carcinoma and dysplasia patients.

Mete Eyigor1, Hulya Eyigor, Ustun Osma, Mustafa Deniz Yilmaz, Nuray Erin, Omer Tarik Selcuk, Cem Sezer, Meral Gultekin, Sadi Koksoy.   

Abstract

BACKGROUND: Although the imbalance of cytokines in Head and Neck Squamous Cell Carcinoma (HNSCC) is well known, there is scarce data regarding its occurrence during dysplasia, before the malignant transformation.
OBJECTIVE: To determine whether laryngeal dysplasia patients show a different cytokine profile than patients with cancer and healthy controls.
METHODS: Seventeen newly diagnosed, untreated larynx squamous cell carcinoma (SCC) and six laryngeal dysplasia patients as well as 22 healthy controls were analyzed for circulating cytokines. A flowcytometry Th1/Th2 cytokine array kit was used to quantitatively measure Interleukin-2 (IL-2), IL-4, IL-6, IL-10, Tumor Necrosis Factor-α (TNF-α) and Interferon-γ (IFN-γ) levels. Additionally, IL-8 levels were determined through ELISA.
RESULTS: IL-6, IL-8 and IL-10 were determined to be statistically increased in SCC patients (p<0.05). IL-8 and IL-10 levels were also higher in SCC patients than dysplasia patients (p<0.05). Additionally, IL-6 and IL-10 were all found to be markedly increased in dysplasia patients compared with controls (p<0.05).
CONCLUSION: Our results demonstrate an imbalance of IL-6 and IL-10 not only in HNSCC but also in laryngeal dysplasia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25549593     DOI: IJIv11i4A4

Source DB:  PubMed          Journal:  Iran J Immunol        ISSN: 1735-1383            Impact factor:   1.603


  4 in total

1.  Interleukin 6 as a potential diagnostic and prognostic biomarker in saliva in patients with carcinoma of the larynx.

Authors:  D Milisavljevic; M Krstic; T Stankovic
Journal:  Hippokratia       Date:  2016 Apr-Jun       Impact factor: 0.471

Review 2.  T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma.

Authors:  Daniele Maggioni; Lorenzo Pignataro; Werner Garavello
Journal:  Oncoimmunology       Date:  2017-05-04       Impact factor: 8.110

3.  Rapamycin targets Interleukin 6 (IL-6) expression and suppresses endothelial cell invasion stimulated by tumor cells.

Authors:  Oleksandr Ekshyyan; Alok R Khandelwal; Xiaohua Rong; Tara Moore-Medlin; Xiaohui Ma; Jonathan Steven Alexander; Cherie-Ann O Nathan
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

4.  HNSCC subverts PBMCs to secrete soluble products that promote tumor cell proliferation.

Authors:  Marcell Costa de Medeiros; Rajat Banerjee; Min Liu; Giovana Anovazzi; Nisha J D'Silva; Carlos Rossa Junior
Journal:  Oncotarget       Date:  2017-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.